Arlington Trust’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$346K Buy
887
+100
+13% +$42.3K 0.03% 78
2026
Q1
$372K Buy
787
+37
+5% +$18.6K 0.03% 65
2025
Q4
$350K Sell
750
-1,536
-67% -$713K 0.04% 61
2025
Q3
$974K Hold
2,286
0.18% 68
2025
Q2
$876K Sell
2,286
-250
-10% -$90.1K 0.17% 69
2025
Q1
$876K Hold
2,536
0.19% 71
2024
Q4
$761K Sell
2,536
-200
-7% -$69.9K 0.16% 78
2024
Q3
$1.11M Hold
2,736
0.24% 56
2024
Q2
$879K Hold
2,736
0.21% 64
2024
Q1
$913K Sell
2,736
-109
-4% -$33.3K 0.23% 59
2023
Q4
$770K Buy
2,845
+2,808
+7,589% +$694K 0.22% 63
2023
Q3
$9.1K Buy
+37
New +$10.1K ﹤0.01% 241

Other funds holding HCA

Arlington Trust's HCA Position: Q2 2026 in Review

Arlington Trust increased its HCA Healthcare (HCA) stake by 13% in Q2 2026, buying an estimated $42.3K and bringing the position to 887 shares worth $346K. The position accounts for 0.03% of the portfolio, ranked #78.

Arlington Trust first reported a position in HCA in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.11M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Arlington Trust held 887 shares of HCA Healthcare worth $346K as of Q2 2026.
  • Arlington Trust bought 100 HCA Healthcare shares in Q2 2026, an estimated $42.3K.
  • HCA Healthcare made up 0.03% of Arlington Trust's portfolio in Q2 2026, its #78 holding.
  • Arlington Trust first reported a position in HCA Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Arlington Trust's HCA Healthcare position peaked at $1.11M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Arlington Trust's 13F filing for Q2 2026, filed 7 Jul 2026.